Category Archives: AZBio News
AZBio News for March 2011
Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement
Ventana Medical Launches Virtuoso Software for Digital Pathology
Catalyst for Growth – AZ Bio moves forward with new CEO and an aggressive agenda
MSDx Awarded $226,000 Arizona Commerce Authority Grant
AdvaMed Appoints Regenesis Biomedical Chief Executive to Board of Directors
MSDx Awarded $226,000 Arizona Commerce Authority Grant
Funding allows MSDx to launch test kits to the researchers for use in multiple sclerosis research.Continue reading
Critical Path Institute Board of Directors Announces President’s Plans to Retire
C-Path founder Raymond L. Woosley, MD, PhD announces retirement plans.
ASU forms innovative international health care partnership
Agreement establishes 1st Biosignatures Center between ASU and Taiwan’s Chang Gung University – partnership will improve patient outcomes and reduce costs.Continue reading
Arizona companies team up, providing quick development of cancer drugs
TGen Drug Development (TD2) and Flagship Biosciences offer combined oncology and pathology services for pharmaceutical and biotech clients.Continue reading
Flagship Biosciences announces dermatopathology services for pharma clinical trials
Flagship teams with Angela Wyatt Dermatology to offer dermatopathology clinical trials and discovery services to pharma and biotech firms.Continue reading
Pathology delivered digitally in animal health product development
Animal Health Consulting and Flagship Biosciences team to offer virtual pathology in animal health product development.Continue reading
Gore Receives FDA Approval for Innovative GORE® C3 Delivery System for GORE® EXCLUDER® AAA Endoprosthesis
New Innovation Enables Physicians and Interventionalists to Reposition Device for Ideal Placement in Treating Abdominal Aortic AneurysmsContinue reading
2010 News
AZBIO and AZBio Member News in 2010Continue reading